Clinical Course of Children with Campylobacter Gastroenteritis With and Without Co-Infection in Lima, Peru

Galo Amaro Munoz1, Maribel Denise Riveros-Ramirez1,2, Elsa Chea-Woo1

  • 1School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.

Insights

Coinfections with Campylobacter spp. in children aged 12-24 months often present with more severe symptoms than single infections. Macrolide treatment may offer faster recovery for severe coinfection cases.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Clinical Gastroenterology

Background:

  • Gastroenteritis is a common childhood illness, with Campylobacter spp. being a significant pathogen.
  • Understanding the clinical impact of single versus coinfections is crucial for effective treatment.
  • Pediatric populations, particularly those aged 12-24 months, are vulnerable to severe diarrheal diseases.

Purpose of the Study:

  • To compare the clinical presentation and outcomes of Campylobacter spp. gastroenteritis in single infections versus coinfections.
  • To evaluate the impact of empirical antibiotic treatment, specifically macrolides, on clinical course.
  • To analyze treatment responses in relation to infection type (single vs. coinfection) and severity.

Main Methods:

  • Descriptive study of a pediatric cohort in Lima, Peru (2008-2011).
  • Evaluation of 96 diarrheal episodes with positive Campylobacter spp. cultures.
  • Analysis of clinical data including symptom duration, frequency of bowel movements, vomiting, and fever, stratified by infection type and treatment.

Main Results:

  • Coinfections (64.6%) were more frequent than single infections, often involving Escherichia coli, norovirus, or Giardia.
  • Coinfections exhibited longer symptom duration (6.6 vs. 5.7 days), higher bowel movement frequency (18.9 vs. 14.8), and increased rates of vomiting and fever compared to single infections.
  • Patients with severe coinfections treated with macrolides showed a potential for faster recovery than those treated with non-macrolides.

Conclusions:

  • Campylobacter spp. coinfections in young children generally lead to more severe gastroenteritis than single infections.
  • Empirical macrolide treatment may be associated with improved clinical outcomes in severe cases of Campylobacter coinfection.
  • Further research is warranted to confirm the efficacy of macrolides in managing severe pediatric Campylobacter coinfections.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
61
Stages of Infection01:26

Stages of Infection

Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
59.5K
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
79
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
57
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
35
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
219